Attached files

file filename
10-K - ANNUAL REPORT - NEXUS BIOPHARMA INCf10k2017_nexusbiopharma.htm
EX-31.1 - CERTIFICATION - NEXUS BIOPHARMA INCf10k2017ex31i_nexusbiopharma.htm

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Nexus Biopharma, Inc. (the “Company”) on Form 10-K for the fiscal year ended February 28, 2017 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Warren Lau, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

July 5, 2017 /s/ Warren Lau
  Warren Lau
  Chief Executive Officer and
  Chief Financial Officer